For Physicians & Clinicians

Catch what MoCA and MMSE miss. Bill it through Medicare.

The MCI Screen is the only brief cognitive assessment built specifically to catch mild cognitive impairment — not dementia. 97.3% accuracy, in your staff’s hands, billable under codes you already use.

Start a Clinic PilotSee the Clinical Evidence
Every other tool was built to catch dementia. Ours catches what comes before it.
ToolSens.Spec.AccuracyMedicare
MCI Screen (Acurist)95%97%97.3%Yes
MoCA74–84%60%~70%Yes
MMSE71%36%~54%No
Clock Drawing54%39%~47%Yes
Mini-Cog84%79%~82%Yes
Source: Journal of Alzheimer’s Disease, 2007 · Trenkle, Shankle & Azen. Accuracy = balanced accuracy (mean of sensitivity and specificity), except MCI Screen (published overall accuracy).
Sample MCI Screen Report Output
Overall ImpressionBelow Normal
Memory Performance Index43/100 — Impaired
Recall PatternImpaired (AD pattern)
Immediate Recall11/30 — Moderately Impaired
Suggested next stepBilateral hippocampal workup
Proof in Practice

Where Acurist is already in use.

Health systems, trial sponsors, and population-health programs across the US and Japan use the MCI Screen in clinical practice, research recruitment, and risk-based screening.

Health systems & clinics
Cleveland Clinic Lou Ruvo Center for Brain Health · Mayo Clinic · Hoag Hospital · St. Joseph’s Health
Integrated into memory-care and Annual Wellness Visit workflows for objective MCI screening and longitudinal monitoring.
Trial sponsors & researchers
AstraZeneca · NIH-funded studies · USC · UC Irvine
Selected for prodromal-MCI cohort enrichment and longitudinal cognitive tracking in Alzheimer’s disease research.
Population health & insurers
Mass Mutual · New York Life · Pacific Life · Japanese Federal Government
Deployed at scale for risk-stratified early-detection screening across senior populations.

Looking for a specific case study with deployment metrics? Contact our team — we can share results from comparable programs under NDA.

The Problem

Cognitive impairment is being missed in primary care.

<50%
of primary care physicians routinely assess older adults for cognitive impairment.
Source: Alzheimer’s Association, 2024 Facts & Figures Report
1 in 9
Americans age 65 and older is living with Alzheimer’s dementia — and millions more have MCI, a treatable early stage best caught with a validated screen.
Source: Alzheimer’s Association, 2024 Facts & Figures

The MMSE — still the most widely used cognitive assessment in America — detects MCI with just 71% sensitivity and 36% specificity. Patients are slipping through.

Both the American Academy of Family Physicians and Medicare emphasize cognitive assessment in older adults: AAFP supports targeted screening and publishes the AAFP Cognitive Care Kit for family physicians, and Medicare requires detection of cognitive impairment as a core component of the Annual Wellness Visit (G0438/G0439). Acurist removes the barriers to acting on that requirement — validated, clinically proven assessments delivered before the visit.

What Acurist Delivers

Everything you need. Nothing you don’t.

🧠

MCI Screen & Memory Screen

Brief, validated assessments in 12–15 minutes by any trained staff member. No specialist credentials required. Done in-person, by phone, or via telehealth.

📋

One-Page Clinician Report

Automatic scoring and instant report. Memory Performance Index, recall pattern analysis, and domain breakdown ready before the physician enters the room.

Actionable Care Plan

Diagnostic checklist, medication review prompts, lifestyle recommendations, and referral pathways pre-populated based on the patient’s specific results.

Coming Soon
💻

EMR Templates

Templated notes and documentation checklists to reduce administrative burden and support AWV and cognitive care planning billing codes. Currently in development.

📈

Memory Performance Index (MPI)

A 0–100 cognitive composite that quantifies memory function across recall, recognition, and retention. The MPI gives clinicians a defensible, trackable number for documentation, longitudinal comparison, and patient communication — calculated automatically with every MCI Screen.

🎓

Clinician Training & Support

Minimal training required. Short onboarding modules, quick reference guides, and report interpretation guidelines. One practice session achieves test-retest reliability of 0.83 — most staff are ready after a single training video.

The Workflow

Fits into any visit. Adds value to every one.

Integrate the MCI Screen into Annual Wellness Visits, chronic care checkups, or any visit where cognitive concerns arise.

1

Physician or trained staff member administers the MCI Screen

No specialist credentials required. 12–15 minutes. Done in-person, by phone, or via telehealth.

2

Acurist auto-scores and generates the report

Instant results. Memory Performance Index and recall pattern analysis ready before the physician enters.

3

Physician reviews the one-page report

Overall impression (Normal / Borderline / Below Normal), MPI score, diagnostic clues, and next steps adjusted for age, sex, race, and education.

4

Action plan delivered to patient

Patient-facing summary and referral prompts — shareable as PDF or via secure FHIR export to any connected EHR.

Reimbursement & Practice Economics

The MCI Screen is reimbursed by Medicare and PPO insurers under established CPT codes for cognitive testing and care planning.

MCI Screen administration (physician/QHP)96136
MCI Screen administration (technician/MA)96138
Test interpretation & evaluation96132
Annual Wellness Visit (AWV)G0438 / G0439
Cognitive Assessment & Care Plan99483
Typical CMS national payment: administration ~$34–$43, interpretation ~$130 (geographic variation applies). Acurist provides documentation checklists and EMR templates to support billing.
Clinical Evidence

The MCI Screen is clinically validated

Four independent peer-reviewed studies. Validated across 121,000+ patients in the US and Japan.

MCI vs. Normal
97.3%
Overall accuracy
95%
Sensitivity — catching true MCI cases
88%
Specificity — correctly clearing normal patients
3+ Yrs
Predictive power before AD symptom onset
Mild Dementia vs. Normal
99%
Overall accuracy
96%
Sensitivity
99%
Specificity
121,000+
Patients validated across US & Japan
Proceedings of the National Academy of Sciences · 2005
Methods to Improve the Detection of Mild Cognitive Impairment
Shankle WR, Romney AK, Hara J, et al. · UC Irvine
Journal of Alzheimer’s Disease · 2007
Detecting Cognitive Impairment in Primary Care: Performance Assessment of Three Screening Instruments
Trenkle DL, Shankle WR, Azen SP · USC Keck School of Medicine
American Journal of Alzheimer’s Disease · 2008
The Japanese MCI Screen for Early Detection of Alzheimer’s Disease
Cho A, Sugimura M, Nakano S, et al. · Fukuoka University
Journal of Prevention of Alzheimer’s Disease · 2023
Predicting Clinical Decline Over 36 Months with a Memory-Based Digital Biomarker
Bruno D, Zinkunegi AJ, Bock JR
Resources for Healthcare Providers

Validated, clinically proven cognitive intelligence for your clinic.

Report Interpretation Guide

Designed to help physicians and healthcare professionals interpret MCI Screen results, including overall impression, MPI scoring, and sub-score guidance.

Download PDF →

Clinical Studies

The MCI Screen combines high precision with practical administration. Download our full accuracy validation study and peer-reviewed publications.

Download PDF →

Cognitive Tests Comparison Chart

Side-by-side comparison of MCI Screen against MMSE, MoCA, Clock Drawing, and other commonly used cognitive assessments across accuracy, sensitivity, and reimbursement.

Download PDF →

Your patients need this.

Set up your free 15-day trial in minutes. Currently used by physicians and leading health systems — resulting in millions of MCI Screens administered.

Start Your Free 15-Day Trial →Schedule a Call